AI has already become entrenched in pharma and health companies, but COVID-19 is driving faster innovations. AI was already very much on the pharma and health industries’ radar, but the COVID-19 outbreak has considerably accelerated its adoption and use-case rates. The current use cases give a peak into the future of pharma- and healthcare-related technology.